Literature DB >> 2168305

The antiphospholipid antibody dilemma.

R H Derksen1, P Hasselaar, J D Oosting, P G De Groot.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2168305     DOI： 10.1007/BF02205550

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  59 in total

1.  Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature.

Authors:  K Lechner; I Pabinger-Fasching
Journal:  Haemostasis       Date:  1985

2.  Lupus anticoagulant in pregnancy.

Authors:  R L Prentice; P A Gatenby; R H Loblay; R P Shearman; H Kronenberg; A Basten
Journal:  Lancet       Date:  1984-08-25       Impact factor: 79.321

3.  Lupus anticoagulant and thrombosis in systemic lupus erythematosus.

Authors:  P Jungers; F Liote; M D Dautzenberg; C Gazengel; M Dougados; F Tron; J F Bach
Journal:  Lancet       Date:  1984-03-10       Impact factor: 79.321

4.  Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.

Authors:  M A Khamashta; E N Harris; A E Gharavi; G Derue; A Gil; J J Vázquez; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

5.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

6.  Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.

Authors:  H I Glueck; K S Kant; M A Weiss; V E Pollak; M A Miller; M Coots
Journal:  Arch Intern Med       Date:  1985-08

7.  Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus.

Authors:  A Vismara; P L Meroni; A Tincani; E N Harris; W Barcellini; A Brucato; M Khamashta; G R Hughes; C Zanussi; G Balestrieri
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

8.  Cultured human endothelial cells generate tissue factor in response to endotoxin.

Authors:  M Colucci; G Balconi; R Lorenzet; A Pietra; D Locati; M B Donati; N Semeraro
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

9.  Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis.

Authors:  H Awada; G Barlowatz-Meimon; M Dougados; P Maisonneuve; Y Sultan; B Amor
Journal:  J Lab Clin Med       Date:  1988-02

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307
View more
  2 in total

Review 1.  Systemic lupus erythematosus and pregnancy.

Authors:  R H Derksen
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus. Relationship with Raynaud's phenomenon, disease activity, inflammatory indices, anticardiolipin antibodies and corticosteroid therapy.

Authors:  A Doria; A Ghirardello; M Boscaro; M L Viero; E Vaccaro; G M Patrassi; P F Gambari
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.